Anti-Asthmatic Agents
dc.contributor.author | Hirabayashi, Katie |
dc.contributor.other | Children's Hospital of Philadelphia |
dc.date.accessioned | 2025-05-05T14:06:52Z |
dc.date.created | 2024-04-08 |
dc.description | This concept set was developed by a data scientist (KH) for a study led by CHOP clinicians Dr. Jonathan Spergel and Dr. Stan Gabryszewski, which investigates dupilumab use and autoimmune diseases in patients with asthma and atopic dermatitis. The codeset was used to identify patients with indication of moderate-to-severe asthma, based on their combinations of asthma drugs. The codeset is designed for use with the PEDSnet data model. The "category" column includes various types of asthma drugs, which together may provide information about asthma severity: injection, short-acting beta agonist (SABA), leukotriene receptor antagonists (LTRA), inhaled corticosteroids (ICS), long-acting beta agonist (LABA), combination ICS and LABA (combo), Cromolyn, zileuton, and theophylline. |
dc.description.abstract | Concept set intended to identify patients with asthma medications for the purpose of defining a study cohort of patients with moderate-to-severe asthma. |
dc.identifier.uri | https://pedsnet.org/metadata/handle/20.500.14642/1016 |
dc.language.iso | en-US |
dc.provenance | This concept set was developed for the "Effect of Dupilumab on Onset of Type 1 Disease" study (Incidence of Autoimmune Diseases in Children with Atopy Treated with Dupilumab) to define a cohort of patients with moderate-to-severe atopic disease, including moderate-to-severe asthma. |
dc.publisher | PEDSnet |
dc.relation.uri | https://github.com/PEDSnet/dupilumab_t1/blob/main/functions/codeset_generation.R#L1179-L1274 |
dc.rights | a CC-BY Attribution 4.0 license. |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.subject | PEDSnet Data Model |
dc.subject | No Formal Review |
dc.subject | Cohort Definition |
dc.subject | Ingredient |
dc.subject | Semantic Branded Drug |
dc.subject | Semantic Branded Drug Group |
dc.subject | Semantic Branded Drug Form |
dc.subject | Semantic Branded Drug Component |
dc.subject | Semantic Clinical Drug |
dc.subject | Semantic Clinical Drug Group |
dc.subject | Semantic Clinical Drug Form |
dc.subject | Semantic Clinical Drug Component |
dc.subject.mesh | Adrenergic Receptor Agonist |
dc.subject.mesh | Sympathomimetic Agent |
dc.subject.mesh | Nonsteroidal Anti-inflammatory Drug |
dc.subject.mesh | Corticosteroid |
dc.subject.mesh | Receptor Agonist |
dc.subject.mesh | Anti-infective |
dc.subject.mesh | Hormone |
dc.subject.mesh | Steroid |
dc.subject.other | RxNorm |
dc.subject.other | RxNorm Extension |
dc.title | Anti-Asthmatic Agents |
dspace.entity.type | ConceptSet |
local.admin.note | pedsnet_dcc_v53 |
local.quality.status | Research-Ready |
local.subject.flat | PEDSnet Data Model |
local.subject.flat | No Formal Review |
local.subject.flat | Cohort Definition |
local.subject.flat | Ingredient |
local.subject.flat | Semantic Branded Drug |
local.subject.flat | Semantic Branded Drug Group |
local.subject.flat | Semantic Branded Drug Form |
local.subject.flat | Semantic Branded Drug Component |
local.subject.flat | Semantic Clinical Drug |
local.subject.flat | Semantic Clinical Drug Group |
local.subject.flat | Semantic Clinical Drug Form |
local.subject.flat | Semantic Clinical Drug Component |
relation.isDocumentationOfConceptSet | 3607ba36-3c7b-4ebc-822e-fc0bfcfee416 |
relation.isDocumentationOfConceptSet.latestForDiscovery | 7156b9cb-99cf-430f-acc6-040fe7398373 |
relation.isStudyOfConceptSet | 923eec9d-2cca-497f-9d68-d47643c5654d |
relation.isStudyOfConceptSet.latestForDiscovery | 923eec9d-2cca-497f-9d68-d47643c5654d |
Files
Original bundle
1 - 1 of 1